Get access

Oligomerization of SLC4A11 protein and the severity of FECD and CHED2 corneal dystrophies caused by SLC4A11 mutations

Authors

  • Gonzalo L. Vilas,

    1. Membrane Protein Disease Research Group, Department of Physiology and Department of Biochemistry, School of Molecular and Systems Medicine, University of Alberta, Edmonton, Canada
    Search for more papers by this author
  • Sampath K. Loganathan,

    1. Membrane Protein Disease Research Group, Department of Physiology and Department of Biochemistry, School of Molecular and Systems Medicine, University of Alberta, Edmonton, Canada
    Search for more papers by this author
  • Anita Quon,

    1. Membrane Protein Disease Research Group, Department of Physiology and Department of Biochemistry, School of Molecular and Systems Medicine, University of Alberta, Edmonton, Canada
    Search for more papers by this author
  • Periasamy Sundaresan,

    1. Department of Genetics, Dr. G. Venkataswamy Eye Research Institute, Aravind Medical Research Foundation, Madurai, India
    Search for more papers by this author
  • Eranga N. Vithana,

    1. Singapore Eye Research Institute, Singapore National Eye Centre, 11 Third Hospital Avenue, Singapore
    2. Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
    Search for more papers by this author
  • Joseph Casey

    Corresponding author
    1. Membrane Protein Disease Research Group, Department of Physiology and Department of Biochemistry, School of Molecular and Systems Medicine, University of Alberta, Edmonton, Canada
    • Department of Physiology, University of Alberta, Edmonton, Alberta, Canada T6G 2H7

    Search for more papers by this author
    • http://www.physiology.ualberta.ca/Home/People/Academic/casey.cfm


  • Communicated by Andreas Gal

Abstract

Mutations in the SLC4A11 gene, which encodes a plasma membrane borate transporter, cause recessive congenital hereditary endothelial corneal dystrophy type 2 (CHED2), corneal dystrophy and perceptive deafness (Harboyan syndrome), and dominant late-onset Fuchs endothelial corneal dystrophy (FECD). We analyzed missense SLC4A11 mutations identified in FECD and CHED2 patients and expressed in transfected HEK 293 cells. Chemical cross-linking and migration in nondenaturing gels showed that SLC4A11 exists as a dimer. Furthermore, co-immunoprecipitation of epitope-tagged proteins revealed heteromeric interactions between wild-type (WT) and mutant SLC4A11 proteins. When expressed alone, FECD- and CHED2-causing mutant SLC4A11 proteins are primarily retained intracellularly. Co-expression with WT SLC4A11 partially rescued the cell surface trafficking of CHED2 mutants, but not FECD mutants. CHED2 alleles of SLC4A11 did not affect cell surface processing of WT SLC4A11. In contrast, FECD mutants reduced WT cell surface processing efficiency, consistent with dominant inheritance of FECD. The reduction in movement of WT protein to the cell surface caused by FECD SLC4A11 helps to explain the dominant inheritance of this disorder. Similarly, the failure of CHED2 mutant SLC4A11 to affect the processing of WT protein, explains the lack of symptoms found in CHED2 carriers and the recessive inheritance of the disorder. Hum Mutat 33:419–428, 2012. © 2011 Wiley Periodicals, Inc.

Get access to the full text of this article

Ancillary